Editor's note: Seeking Alpha is proud to welcome John Hamblin as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more »
Biospecifics is a biopharma company which develops injectable collagenase (Xiaflex) for multiple indications including Peyronie's disease and Dupuytren's contracture. The company has a very unique business model. They initiate the development of indications for Xiaflex, which they hold patents on. Endo Pharmaceuticals then has the option to take over